Monarch Partners Asset Management LLC grew its holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Rating) by 4.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 62,327 shares of the biotechnology company’s stock after purchasing an additional 2,743 shares during […]
Chicago Capital LLC cut its holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Rating) by 30.5% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 319,054 shares of the biotechnology company’s stock after selling 140,261 shares during the period. Chicago Capital LLC owned about 1.89% of Ligand […]
Villere ST Denis J & Co. LLC decreased its stake in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Rating) by 1.6% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 483,347 shares of the biotechnology company’s stock after selling 7,760 shares during the quarter. Ligand Pharmaceuticals comprises 2.5% of Villere ST Denis J […]